Molecule Details
InChIKeyXYLJNLCSTIOKRM-UHFFFAOYSA-N
Compound NameBrimonidine
Canonical SMILESBrc1c(NC2=NCCN2)ccc2nccnc12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Homologous
Avg pChEMBL7.49
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00484
Drug NameBrimonidine
CAS Number59803-98-4
Groups approved investigational
ATC Codes D11AX21 S01EA55 S01GA07 S01EA05
DescriptionBrimonidine is an alpha-adrenergic agonist and 2-imidazoline derivative that was first introduced in 1996.[A178951] It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors.[A179002] Brimoni...

Categories: Adrenergic Agents Adrenergic Agonists Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Antiglaucoma Preparations and Miotics Cardiovascular Agents Central Nervous System Depressants Decongestants and Antiallergics Dermatologicals Heterocyclic Compounds, Fused-Ring Hypotensive Agents Misc. Skin and Mucous Membrane Agents Ophthalmologicals Quinoxalines Sensory Organs Sympathomimetics Used as Decongestants Sympathomimetics in Glaucoma Therapy
Cross-references: BindingDB: 34572 ChEBI: 3175 CHEMBL844 ChemSpider: 2341 Drugs Product Database (DPD): 11710 Guide to Pharmacology: 520 IUPHAR: 520 C07886 D07540 PDB: J59 PharmGKB: PA448665 PubChem:2435 PubChem:46507305 RxCUI: 134615 Therapeutic Targets Database: DAP000280 Wikipedia: Brimonidine ZINC: ZINC000021303210
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P08913 ADRA2A Homo sapiens Human PF00001 8.6 Ki ChEMBL;BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 8.0 Ki ChEMBL;BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 7.4 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 6.0 Ki ChEMBL
DrugBank Target Actions (4)
Target Gene Target Name Action Type
Q06278 AOX1 Aldehyde oxidase substrate enzymes
P08913 ADRA2A Alpha-2A adrenergic receptor agonist targets
P18089 ADRA2B Alpha-2B adrenergic receptor agonist targets
P18825 ADRA2C Alpha-2C adrenergic receptor agonist targets